Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw

Medication-related osteonecrosis of the jaw (MRONJ) was first reported more than a decade ago. Since then, numerous cases have been diagnosed. Currently, there are three groups of drugs related to MRONJ: bisphosphonates, denosumab and anti-angiogenic drugs. As MRONJ can lead to debilitating clinical...

Full description

Bibliographic Details
Main Author:	Winnie Zee Man Wat
Format:	Article
Language:	English
Published:	MDPI AG 2016-10-01
Series:	Dentistry Journal
Subjects:	osteonecrosis of the jaw BRONJ MRONJ DRONJ bisphosphonate zoledronate denosumab anti-angiogenic
Online Access:	http://www.mdpi.com/2304-6767/4/4/38

Similar Items

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) in cancer patients
by: A K Ebzeev
Published: (2020-04-01)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
by: Mario Migliario, et al.
Published: (2017-03-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw
by: Siri Paulo, et al.
Published: (2020-04-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know
by: Emanuel Bruckmoser, et al.
Published: (2021-04-01)

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
by: Falk Wehrhan, et al.
Published: (2019-03-01)

Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases
by: Fang, Y.-Q, et al.
Published: (2023)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
by: Johannes Laimer, et al.
Published: (2021-04-01)

Osteonecrosis of the jaw after dental implant placement. A case report
by: J.L. Calvo-Guirado, et al.
Published: (2014-03-01)

Osteonecrosis of jaw associated with bisphosphonate use
by: Ashu Rastogi, et al.
Published: (2012-01-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

RANK-Ligand inhibitor associated osteonecrosis of the jaw
by: Rashad, Ashkan, et al.
Published: (2013-11-01)

From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights
by: Alexandre Anesi, et al.
Published: (2019-10-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report
by: Manzon L, et al.
Published: (2014-08-01)

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

Medication-related osteonecrosis of the jaw treatment modalities: A review
by: Amir Ali Asadi
Published: (2020-08-01)

Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
by: Mihaylova Z., et al.
Published: (2019-05-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
by: Pramod S Sankar, et al.
Published: (2018-01-01)

Clinical diagnosis and treatment on bisphosphonate⁃related osteonecrosis of the jaw
by: YIN Xue⁃min, et al.
Published: (2017-03-01)

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw
by: Siri Paulo, et al.
Published: (2019-06-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)